Countdown to the Joint Meeting of ASMB, HCS, and ASIP

Mark your calendars for this highly anticipated meeting in Salt Lake City, UT, October 22-25, 2023.


Tissue, Matrix, and Pathobiology is an exciting new multidisciplinary and collaborative joint meeting of the American Society for Matrix Biology (ASMB), The Histochemical Society (HCS), and the American Society for Investigative Pathology (ASIP). The Program Committee has put together a fantastic four-day lineup of speakers, career sessions, workshops, and events—and can’t wait to welcome you in Salt Lake City!

Who Should Attend

Students, trainees, investigators, and educators who are working on cutting-edge basic, clinical, and translational research related to biology of cells and tissues, as well as molecular and cellular alterations that drive disease processes.

Scientific Programming

The scientific program includes award lectures, plenary sessions, symposia, and workshops featuring speakers who are leaders in their respective fields of study. Thematic highlights include:

  • Extracellular Matrix Biology
  • Liver Pathobiology
  • Cardiovascular Diseases
  • ECM Receptors
  • Pathobiology of Fibrosis
  • Cancer Pathobiology
  • Matrix Disorders
  • Neuropathology
  • Organoid Models of Disease
  • Mechanobiology
  • Inflammatory and Infectious diseases
  • Cell-Matrix Interactions

The meeting will also feature education and career development sessions that are focused on the needs of the current generation of trainees and young investigators. A generous scholar award program will provide travel grants for trainees and junior faculty who are members of the participating Societies. View the full program.

 


Thanks to Our Sponsors

ASF Logo

ASF Logo

AJP Logo

Earlier

 

Escheloon Biosciences Logo

Elsevier Logo

Marfan Logo

Nippi Logo

 

Optics 11 Life Logo

PRS Logo

StemBioSys Logo

ThermoFisher Scientific Logo

 

Funding for this conference was made possible (in part) by 1R13AR083265-01 from the National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) and all co-funding support provided by National Heart, Lung, and Blood Institute (NHLBI). The views expressed in written conference materials or publications and by speakers and moderators do not necessarily reflect the official policies of the Department of Health and Human Services; nor does mention by trade names, commercial practices, or organizations imply endorsement by the U.S. Government.

ASF Logo

Earlier

Home